These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3539511)

  • 21. Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
    Aubert JF; Waeber B; Nussberger J; Vavrek R; Stewart JM; Brunner HR
    Agents Actions Suppl; 1987; 22():349-54. PubMed ID: 3324717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I.
    Häckl LP; Cuttle G; Dovichi SS; Lima-Landman MT; Nicolau M
    Pharmacology; 2002 Aug; 65(4):182-6. PubMed ID: 12174832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiopathogenesis of excess methylprednisolone arterial hypertension in the rat.
    Ribeiro AB; Franco RJ; Kohlmann O; Marson O; Ramos OL
    Clin Exp Hypertens (1978); 1981; 3(6):1219-37. PubMed ID: 6277579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of captopril on responses to bradykinin in the hindquarters vascular bed of the rat.
    Nossaman BD; Kaye AD; Kang B; Feng CJ; Kadowitz PJ
    Peptides; 1997; 18(4):491-4. PubMed ID: 9210166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of uterine smooth muscle bradykinin receptors by bradykinin levels and angiotensin converting enzyme inhibitor in the rat.
    Yasujima M; Matthews PG; Johnston CI
    Clin Exp Pharmacol Physiol; 1981; 8(5):515-8. PubMed ID: 6276064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R; Tunney A; Martinez P
    Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?
    Ribuot C; Cardinal R; Gouin L; Moreau P; Godin D; Vermeulen M; de Champlain J; Rochette L; Nadeau R
    Cardiovasc Res; 1994 Feb; 28(2):221-7. PubMed ID: 8143304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
    Rasmussen S; Leth A; Ibsen H; Damkjaer Nielsen M; Nielsen F; Giese J
    Acta Med Scand; 1985; 218(5):435-42. PubMed ID: 3004113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced reactivity to bradykinin, angiotensin I and the effect of captopril in the pulmonary vasculature of chronically hypoxic rats.
    Russell PC; Emery CJ; Cai YN; Barer GR; Howard P
    Eur Respir J; 1990 Jul; 3(7):779-85. PubMed ID: 2261965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Hypertension; 1981; 3(2):269-76. PubMed ID: 6260647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment.
    Mullane KM; Moncada S
    Eur J Pharmacol; 1980 Sep; 66(4):355-65. PubMed ID: 6998710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the renin-angiotensin system in the development of thyroxine-induced hypertension.
    García del Rio C; Moreno MR; Osuna A; de Dios Luna J; García-Estañ J; Vargas F
    Eur J Endocrinol; 1997 Jun; 136(6):656-60. PubMed ID: 9225731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinin contribution to renal vasodilator effect of captopril in rabbit.
    Hajj-ali AF; Zimmerman BG
    Hypertension; 1991 Apr; 17(4):504-9. PubMed ID: 1849501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
    Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats.
    Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D
    Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats.
    Sharma JN; Abbas SA
    Pharmacol Res; 2005 Sep; 52(3):211-5. PubMed ID: 16026715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
    Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA
    J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antihypertensive effect of acute intracerebroventricular administration of captopril in Dahl salt-sensitive rats.
    Lark LA; Weyhenmeyer JA
    Eur J Pharmacol; 1992 Nov; 222(1):33-7. PubMed ID: 1468497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.